BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression Studies Pharmaceutical Investing
Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US for Its Lead Clinical Development Program - Ketamine-Assisted Therapy for Alcohol Use Disorder Company News
Optimi Health CEO William Ciprick: Uniquely Positioned to Provide Functional Psychedelics Regimen Psychedelics Investing
Nirvana Life Sciences Announces Approval To Build Vancouver Facility From Health Canada Psychedelics Investing
Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of Psilocybin, MDMA Psychedelics Investing
Nirvana Life Sciences announces filing of Patent for novel isolation of 4-PO-Psilocin Prodrug Compound Psychedelics Investing
BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference Pharmaceutical Investing
Lobe Sciences Ltd. and Clearway Global LLC Enter into a Development Agreement to Manage Lobe Sciences Ltd.'s Global Regulatory and Development Strategy and its Implementation Pharmaceutical Investing
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies Forum Pharmaceutical Investing
